Known targets — ChEMBL curated mechanism
ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2
The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 known ✓ | P35372 | 3/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 5/20 | 0.51 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.43 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 8/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2784645 | 0.93 | HSD11B1 (0.57) | HSD11B1OPRM1OPRL1MTNR1AMTNR1B | |
| Citric Acid SCHEMBL2782615 | 0.93 | HSD11B1 (0.51) | HSD11B1OPRM1OPRL1HTR1A | |
| Citric Acid SCHEMBL2779516 | 0.92 | HSD11B1 (0.47) | HSD11B1OPRM1OPRL1MTNR1AMTNR1B | |
| Citric Acid SCHEMBL4702260 | 0.90 | HSD11B1 (0.47) | HSD11B1OPRM1OPRL1HTR1A | |
| Citric Acid SCHEMBL2783385 | 0.88 | HSD11B1 (0.51) | HSD11B1OPRM1OPRL1 | |
| Citric Acid SCHEMBL4697783 | 0.85 | HSD11B1 (0.45) | HSD11B1OPRM1OPRL1HTR1A | |
| SCHEMBL2782154 | 0.85 | HSD11B1 (0.58) | HSD11B1OPRM1OPRL1HTR1A | |
| Citric Acid SCHEMBL2782964 | 0.84 | CHRM4 (0.45) | HSD11B1OPRM1OPRL1 | |
| SCHEMBL2782069 | 0.84 | HSD11B1 (0.54) | HSD11B1OPRM1OPRL1MTNR1AMTNR1B | |
| Citric Acid SCHEMBL2783091 | 0.84 | CHRM4 (0.52) | HSD11B1OPRM1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7759385-B2 | 4-substituted 1-aminocyclohexane compounds for utilization as ORL1-receptor and mu-opiate receptor ligands | GRUENENTHAL GMBH (DE) | 2010-07-20 | — | — | US | disclosed |
| US-20050277674-A1 | 4-substituted 1-aminocyclohexane compounds for utilization as ORL1-receptor and mu-opiate receptor ligands | GRUENENTHAL GMBH (DE) | 2005-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050277674-A1 | 4-substituted 1-aminocyclohexane compounds for utilization as ORL1-receptor and mu-opiate receptor ligands | OPRL1, OPRM1, OGFRL1 | OPRM1 2/4885HSD11B1 1807/4885OPRL1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.